Edition:
United States

argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

103.20EUR
18 Apr 2019
Change (% chg)

€-0.60 (-0.58%)
Prev Close
€103.80
Open
€102.10
Day's High
€109.80
Day's Low
€100.70
Volume
268,726
Avg. Vol
118,393
52-wk High
€119.60
52-wk Low
€54.30

About

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused... (more)

Overall

Beta: --
Market Cap(Mil.): €583.54
Shares Outstanding(Mil.): 26.89
Dividend: --
Yield (%): --

Financials

  ARGX.BR Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.07 -- --
ROI: -19.69 8.91 13.83
ROE: -19.69 10.06 15.25

Earnings vs. Estimates